Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)

27.79 +0.76 (+2.81%)

Delayed Quote Updated: 1:36 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amylyx Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List ↗

August 28, 2023

Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.

Via InvestorPlace

Expert Ratings for Amylyx Pharma ↗

August 11, 2023

Via Benzinga

Amylyx Pharmaceuticals Reports Second Quarter 2023 Financial Results

August 10, 2023

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

A Preview Of Amylyx Pharma's Earnings ↗

August 09, 2023

Via Benzinga

Amylyx Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 10, 2023

August 03, 2023

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Why Shares of Amylyx Pharmaceuticals Were Up Monday ↗

July 24, 2023

The company got a bump from an analyst's upgrade.

Via The Motley Fool

4 Analysts Have This to Say About Amylyx Pharma ↗

July 24, 2023

Via Benzinga

7 Analysts Have This to Say About Amylyx Pharma ↗

May 31, 2023

Via Benzinga

3 Biotech Stocks to Buy Before Drug Trials End ↗

July 28, 2023

Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.

Via InvestorPlace

Amylyx Stock Has A Good Entry Point, Says Bullish Goldman Sachs ↗

July 24, 2023

Shares of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) jumped in early trading on Monday, after remaining broadly flat last week.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023 ↗

July 24, 2023

Via Benzinga

What 7 Analyst Ratings Have To Say About Amylyx Pharma ↗

May 15, 2023

Via Benzinga

Analyst Expectations for Amylyx Pharma's Future ↗

May 15, 2023

Via Benzinga

Amylyx Pharma Earnings Preview ↗

May 10, 2023

Via Benzinga

Amylyx Pharmaceuticals to Host Virtual Webcast on AMX0035 Progressive Supranuclear Palsy (PSP) Program

July 12, 2023

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

EMA's Advisory Panel Gives Thumbs Down To Amylyx Pharma's Amyotrophic Lateral Sclerosis Treatment ↗

June 23, 2023

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a negative opinion regarding Amylyx Pharmaceuticals Inc's (NASDAQ: AMLX) conditional marketing authorization...

Via Benzinga

Amylyx Pharmaceuticals Receives CHMP Negative Opinion on its Conditional Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union

June 23, 2023

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Amylyx Pharmaceuticals Completes Negotiation Process and Signs Letter of Intent with the pCPA for ALBRIOZA™ for the Treatment of ALS

June 15, 2023

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics? ↗

June 13, 2023

Which of these red-hot biotech stocks is the better buy right now?

Via The Motley Fool

Amylyx Pharmaceuticals to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

June 06, 2023

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

How Biohaven Is Coming 'Out Of Stealth Mode' — And Bullishly Extending A 4-Day Run ↗

June 01, 2023

Shares surged into and out of the company's R&D Day, which included a surprise.

Via Investor's Business Daily

Amylyx Pharmaceuticals Provides Update on Ongoing Regulatory Review of AMX0035 for the Treatment of ALS in the European Union

May 30, 2023

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Amylyx Pharmaceuticals Turns Profitable On Successful Drug Launch

May 16, 2023

Amylyx Pharmaceuticals is the rare young biotech that's profitable. The company earned $0.02 a share in Q1, and analysts expect profitability to grow.

Via MarketBeat

2 Supercharged Growth Stocks to Buy Right Now ↗

May 14, 2023

These two biopharma stocks might be poised for a major breakout.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 12, 2023

Via Benzinga

US Stock Futures Signal Strong Finish To Wobbly Week — But Analyst Still Sees Recession Risk On Horizon ↗

May 12, 2023

Via Benzinga

Amylyx Blows Past Sales Expectations, Reports Unexpected Profit — Shares Rocket ↗

May 11, 2023

The company was expected to post another loss, but instead came in with a gain of 2 cents per share.

Via Investor's Business Daily

Amylyx Pharmaceuticals Reports First Quarter 2023 Financial Results

May 11, 2023

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

Amylyx Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023

May 05, 2023

From Amylyx Pharmaceuticals, Inc.

Via Business Wire

3 Biotechs That Might Get Bought Out in 2023 ↗

April 26, 2023

Biotech is expected to be a hotbed of mergers and acquisitions this year.

Via The Motley Fool

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.